- Home
- CISO vs IXHL Comparison
CISO vs IXHL Comparison
Compare CISO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISO
- IXHL
- Stock Information
- Founded
- CISO 2015
- IXHL 2001
- Country
- CISO United States
- IXHL Australia
- Employees
- CISO N/A
- IXHL N/A
- Industry
- CISO Computer Software: Prepackaged Software
- IXHL
- Sector
- CISO Technology
- IXHL
- Exchange
- CISO Nasdaq
- IXHL Nasdaq
- Market Cap
- CISO 32.7M
- IXHL 39.2M
- IPO Year
- CISO N/A
- IXHL N/A
- Fundamental
- Price
- CISO $1.03
- IXHL $1.93
- Analyst Decision
- CISO
- IXHL
- Analyst Count
- CISO 0
- IXHL 0
- Target Price
- CISO N/A
- IXHL N/A
- AVG Volume (30 Days)
- CISO 312.9K
- IXHL 24.2K
- Earning Date
- CISO 11-18-2024
- IXHL 11-14-2024
- Dividend Yield
- CISO N/A
- IXHL N/A
- EPS Growth
- CISO N/A
- IXHL N/A
- EPS
- CISO N/A
- IXHL N/A
- Revenue
- CISO $54,633,909.00
- IXHL $86,000.00
- Revenue This Year
- CISO $78.76
- IXHL $3,817.06
- Revenue Next Year
- CISO N/A
- IXHL $66.67
- P/E Ratio
- CISO N/A
- IXHL N/A
- Revenue Growth
- CISO 34.87
- IXHL N/A
- 52 Week Low
- CISO $0.26
- IXHL $1.50
- 52 Week High
- CISO $3.84
- IXHL $8.47
- Technical
- Relative Strength Index (RSI)
- CISO 36.83
- IXHL 52.16
- Support Level
- CISO $0.93
- IXHL $1.71
- Resistance Level
- CISO $1.39
- IXHL $2.19
- Average True Range (ATR)
- CISO 0.51
- IXHL 0.16
- MACD
- CISO -0.19
- IXHL -0.00
- Stochastic Oscillator
- CISO 3.30
- IXHL 41.12
About CISO CISO Global Inc.
CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.